Tracking the culprits of insulin resistance 19 February 2018 Lipids are molecules that form the building blocks of the cells comprising our bodies. When some lipids build up, especially in the liver and the muscles, it can lead to insulin resistance. This can lead to type 2 diabetes. Scientists don’t know exactly which lipids trigger insulin resistance, but they have a couple of prime suspects. Associate Professor Nigel Turner from the University of New South Wales has one lipid, C18:0 ceramide, firmly in his sites and thanks to a grant from the Diabetes Australia Research Trust he will be able to investigate further. “Recent studies in animals and humans have shown that insulin resistance in muscle is closely associated with the build-up of C18:0 ceramide,” Associate Professor Turner said. “We have developed some compounds which target the enzymes responsible for producing C:18:0 ceramide, so we want to see if reducing the amount of this lipid could also reduce insulin resistance. “We hope it leads to more effective treatments for people with type 2 diabetes.” Associate Professor Turner’s research is supported by Diabetes Australia through the Diabetes Australia Research Trust. Find out how you can help support research projects like this here.
Media releases 17 August 2026 Diabetes Australia to deliver Insulin Pump Program supporting children and young people Diabetes Australia has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between Diabetes Australia and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading